Hend El Tayebi: The First GEPPMA Molecular Tumor Board
Hend El Tayebi, Full Professor and Director of Pharmacoeconomics Diploma Program at The German University in Cairo, shared a post on LinkedIn:
“GEPPMA is making history!
We’re thrilled to announce the first GEPPMA Molecular Tumor Board — bringing together a powerhouse panel of top-notch clinical and medical oncologists, molecular biologists, and clinical pharmacologists.
This strategic milestone is your chance to witness how cutting-edge science meets real-world clinical decision making – and to learn firsthand how treatment strategies are shaped for patients based on molecular insights.
Why join?
Because understanding the how behind clinical decisions is key to transforming cancer care.
Date: Thursday| September 11th, 2025
Location: The German University in Cairo
Be part of this transformative step towards personalized medicine in oncology.
Secure your spot now by clicking on this link down below!
Deadline is extended till August 10th.”
More posts featuring Hend El Tayebi on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023